{"id":33359,"date":"2014-10-09T08:26:30","date_gmt":"2014-10-09T12:26:30","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=33359"},"modified":"2014-10-09T08:26:30","modified_gmt":"2014-10-09T12:26:30","slug":"why-chimerix-inc-nasdaqcmrxs-shares-plunged","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359","title":{"rendered":"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged?"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 <strong>Chimerix Inc (NASDAQ:CMRX)<\/strong> shares ended Wednesday\u2019s trading session in red as a patient in Dallas who was undergoing the experimental treatment of Chimerix for Ebola died. It is a big disappointment for Chimerix as it received the FDA approval for treating Thomas Duncan on Tuesday. He was just started with the treatment of experimental drug brincidofovir. Duncan was the first individual diagnosed with Ebola in the U.S.<\/p>\n<p style=\"text-align: justify;\"><strong>The story<\/strong><\/p>\n<p style=\"text-align: justify;\">Thomas Eric Duncan came from Liberia on September 20. On September 24, he showed symptoms of the deadly virus and was admitted to Texas Health Resources Hospital for treatment. He was treated in the Texas hospital for two days and later sent back to home. He was again admitted in the Texas hospital on September 28, and it was then he was diagnosed with Ebola. As and when the health officials came to know, they quarantined the people who had direct contact with Thomas Duncan. He flied from Liberia to the U.S. for attending the high-school graduation ceremony of his son. As per the report, he may have contracted Ebola when he was taking an ill neighbor to the hospital in Liberia.<\/p>\n<p style=\"text-align: justify;\"><strong>The treatment<\/strong><\/p>\n<p style=\"text-align: justify;\">Duncan was treated at Texas Health Resources Hospital. The doctors used brincidofovir, the experimental drug developed by Chimerix Inc (NASDAQ:CMRX), for treating Duncan. However, the medication failed to slow the disease\u2019s progress. On the request of doctors, the U.S. FDA granted brincidofovir the investigational status. The medication was then rushed for treatment of Duncan after the approval. The drug is used on one more patient suffering from Ebola. He is admitted at Nebraska hospital.<\/p>\n<p style=\"text-align: justify;\"><strong>The change <\/strong><\/p>\n<p style=\"text-align: justify;\">Chimerix Inc (NASDAQ:CMRX) gained more than 5% on Tuesday when it received the FDA approval for its experimental drug to be used as an investigational drug. However, the gains turned into a loss after death of Duncan. The focus will now remain on the other patient who is admitted at Nebraska hospital and is treated with Chimerix\u2019s experimental drug.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 Chimerix Inc (NASDAQ:CMRX) shares ended Wednesday\u2019s trading session in red as a patient in Dallas who was undergoing the experimental [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":17294,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[10320,5180,5181],"stock_ticker":[],"class_list":["post-33359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-chimerix-inc","tag-chimerix-inc-nasdaqcmrx","tag-nasdaqcmrx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 Chimerix Inc (NASDAQ:CMRX) shares ended Wednesday\u2019s trading session in red as a patient in Dallas who was undergoing the experimental [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-09T12:26:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"645\" \/>\n\t<meta property=\"og:image:height\" content=\"363\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged?\",\"datePublished\":\"2014-10-09T12:26:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\"},\"wordCount\":344,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg\",\"keywords\":[\"Chimerix Inc\",\"Chimerix Inc. (NASDAQ:CMRX)\",\"NASDAQ:CMRX\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\",\"name\":\"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg\",\"datePublished\":\"2014-10-09T12:26:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg\",\"width\":645,\"height\":363},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359","og_locale":"en_US","og_type":"article","og_title":"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged? - Wall Street PR","og_description":"Boston, MA 10\/09\/2014 (wallstreetpr) \u2013 Chimerix Inc (NASDAQ:CMRX) shares ended Wednesday\u2019s trading session in red as a patient in Dallas who was undergoing the experimental [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-09T12:26:30+00:00","og_image":[{"width":645,"height":363,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged?","datePublished":"2014-10-09T12:26:30+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359"},"wordCount":344,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg","keywords":["Chimerix Inc","Chimerix Inc. (NASDAQ:CMRX)","NASDAQ:CMRX"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359","url":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359","name":"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg","datePublished":"2014-10-09T12:26:30+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Chimerix-Inc.-logo.jpg","width":645,"height":363},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/why-chimerix-inc-nasdaqcmrxs-shares-plunged-33359#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Why Chimerix Inc (NASDAQ:CMRX)\u2019s Shares Plunged?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/33359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=33359"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/33359\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/17294"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=33359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=33359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=33359"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=33359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}